France · Question · Question écrite
17173
Question 17173 — pharmacy and medications
Introduced
21 July 2026
Last action
—
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
21 July 2026
Summary
Mr. Hubert Ott alerts the Minister of Health, Families, Autonomy and Persons with Disabilities on the conditions of access to reimbursement of medicinal treatments against obesity, set by the decree of June 10, 2026 modifying the list of pharmaceutical specialties reimbursed to socially insured persons. This reform constitutes a welcome step forward in that it recognizes obesity as a chronic disease requiring treatment under appropriate load. However, its methods of application raise several concrete difficulties. On the one hand, the initial prescription giving entitlement to reimbursement is reserved for a limited number of authorized specialist doctors, practicing within specialized structures, while many patients are already successfully followed by other practitioners equally invested in the management of obesity, but not authorized to establish this prescription. On the other hand, no transitional provision has been made for patients already under treatment: they must obtain an appointment with an authorized doctor before being able to benefit from reimbursement, without retroactive effect, which forces them to finance their treatment themselves for several months, or to interrupt it due to lack of means. In Alsace, authorized structures are very limited in number, which takes the time for first appointments to several months. This situation creates inequality in access to care, to the extent that obesity affects more people with modest incomes, who are least able to afford the cost of treatment for a prolonged period. It also risks generating, in the long term, greater expenses for health insurance in the event of interruption of treatments that are nevertheless effective. He therefore asks whether the Government intends to provide a transitional period for patients already engaged in a course of care, expand the number of doctors authorized to issue the initial prescription and strengthen the territorial coverage of specialized obesity care structures, particularly in insufficiently resourced rural and border areas.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/17/questions/QANR5L17QE17173
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L17QE17173